Adynxx Inc

ADYX OTCMKTS
2.750
-1.200
-30.38%
已收盘, 15:59 06/18 EDT
开盘
3.730
昨收
3.950
最高
3.730
最低
2.420
成交量
3.89万
成交均量(3M)
6.85万
52周最高
19.15
52周最低
2.420
换手率
0.67%
市值
1,597.68万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Adynxx Inc ADYX股票价格,Adynxx Inc股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Adynxx Inc., formerly Alliqua BioMedical, Inc., is a clinical stage biopharmaceutical company. The Company is focused on development of non-opioid therapeutics for the treatment of pain and inflammatory diseases. Its AYX platform utilizes a proprietary technology of non-opioid, disease-modifying transcription factor decoys. Its pipeline includes brivoligide and AYX2. Brivoligide product candidate is a potent and selective inhibitor of the transcription factor EGR1. Brivoligide is being developed for the prevention of post-surgical pain. AYX2 is a potent inhibitor of Kruppel-like Factors (KLF) six, nine and 15, transcription factors that maintain neuronal and glial activities involved in pain. AYX2 is being developed for the long-term suppression of chronic pain.
展开 >

最近浏览

名称
价格
涨跌幅